CA2 and Parkinson disease: Regarding the observed sex differences, in the present meta-analysis, the over-expression of CA2 in PD patients compared to matched controls is significantly stronger in females than in males (females: LFC = 1.1, FDR = 8.2e−4; males: LFC = 0.6, FDR = 0.5).